openPR Logo
Press release

Lung Cancer Therapeutics Market: How the Business Will Grow in 2025? Prominent Players: Astellas Pharma US, Celgene, Merck Sharp & Dohme GmbH, Pfizer, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim Pharmaceutical, Takeda, N

Lung Cancer Therapeutics Market: How the Business Will Grow

The targeted segment is forecast to emerge dominant among various therapies in The Global Lung Cancer Therapeutics Market, finds Fortune Business Insights in a new study. The study is titled “Lung Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026.” According to the study, the global lung cancer therapeutics market will exhibit an exponential CAGR of 13.0% to reach a value of US$ 48,725.9 Mn by 2026 from US$ 18,327.6 Mn in 2018.

Lung cancer is considered one of the leading causes of death by cancer. Cancer can be a result of continuous exposure to asbestos, and unhealthy lifestyle that includes habits such as pipe smoking, cigarette smoking, cigar smoking. The rising incidence of lung cancer is subsequently fuelling demand for various therapies in the global lung cancer therapeutics market.

Browse Complete Report Details:
https://www.fortunebusinessinsights.com/industry-reports/lung-cancer-therapeutics-market-100473

Key Players:
• Astellas Pharma US
• Celgene
• Merck Sharp & Dohme GmbH
• Pfizer
• Eli Lilly and Company
• Bristol-Myers Squibb
• AstraZeneca
• Boehringer Ingelheim Pharmaceutical, Takeda
• Novartis
• Sanofi.

Targeted therapy is expected to emerge dominant among other therapies such as vaccine therapy, radiation therapy, chemotherapy, surgery, and immunotherapy. targeted therapy segment accounted for a share of 51.1% in the year 2018. This is because of the rise in focus towards the diagnosis of lung cancer and the positive outcome of targeted therapy that is increasing its demand in the global market.

However, the immunotherapy segment is anticipated to grow at the fastest CAGR during the forecast period. This is because of the rise in the number of product launches related to treating lung cancer. The availability of abundant resources is creating new opportunities for growth in the market during the coming years.

Increasing Investments in Research and Development Activities to Boost Market

Various factors are responsible for boosting the global lung cancer therapeutics market. One among them is the launch of cancer awareness programs by both government and non-government organizations around the world. Cancer awareness and various treatment measures are increasing the demand for cancer therapeutics, especially in developing nations. Besides this, increasing investment by market players in research and development activities to discover novel therapeutics is driving the global market.

On the flip side, most of the anticipated drugs for lung cancer are still in their early testing stage and might take some time before finally getting launched in the market. This gestation gap between clinical trial and final launch might create uncertainty among players, making them skeptical about further investments in lung cancer treatment researches. This may hamper the market growth during the forecast period.

Furthermore, Cure for a certain type of cancer is yet to be discovered. The cure is yet to be discovered as targeted therapies have no effect on such cancer types. This is more likely to create challenges for the global market for lung cancer therapeutics during the forecast period.

Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-therapeutics-market-100473

The Asia Pacific to Emerge as the Fastest Growing Region with Rising in Cancer Awareness Programs

North America is expected to dominate the global market for lung cancer therapeutics. In 2018 the region generated a revenue of US$ 8,093.2 Mn. Growth in this region is attributable to the rising prevalence and diagnostics of lung cancer and the increasing adoption of advanced lung cancer therapeutics. Besides this, increasing awareness about cancer is enabling the market in Asia Pacific exhibit a faster CAGR.

A few novel therapeutics are introduced in the market, impelling leading players to research on improved medication. For instance, Genentech, a company operating in the lung cancer therapeutics market has recently launched their new drug named, Alecensa (alectinib), in order to treat ALK-positive non-small cell lung cancer. Such strategies adopted by players will bode well for the global lung cancer therapeutics market in the long run.

TABLE OF CONTENT:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Lung Cancer by Key Countries
4.2 Regulatory Scenario by Key Regions
4.3 Key Industry Developments
4.4 Overview of Current Advances in R&D for Lung Cancer Therapeutics
4.5 Pipeline Analysis

Get Discount:
https://www.fortunebusinessinsights.com/enquiry/check-discount/lung-cancer-therapeutics-market-100473

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Therapeutics Market: How the Business Will Grow in 2025? Prominent Players: Astellas Pharma US, Celgene, Merck Sharp & Dohme GmbH, Pfizer, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim Pharmaceutical, Takeda, N here

News-ID: 1814713 • Views: 96

More Releases from Fortune Business Insights Pvt Ltd

Resin Market to Be Positively Impacted by Rising Demand for Light Weight Vehicle …
The global resin market is projected to gain momentum from the rising demand for sustainable packaging for water bottles and food items. This information is published in an upcoming report by Fortune Business Insights™, titled, “Resin Market Size, Share & Industry Analysis, By Type (Polypropylene, Polyvinyl chloride, Polyurethane, Polyethylene terephthalate, Polystyrene, expanded polystyrene, others), By End-Use Industry (Packaging, Building & Construction, Automotive & Transportation, Electrical & electronics, Agriculture, others) and
Refrigerant Market Size, Share, Research Report and Regional Forecast 2026
The global refrigerant market is projected to gain impetus from rapid urbanization and improving lifestyle. These are likely to increase the demand for air-conditioning in commercial and residential infrastructures. Fortune Business Insights™ published this information in an upcoming report, titled, “Refrigerant Market Size, Share & Industry Analysis, By Type (Fluorocarbons, Hydrocarbons, Inorganic refrigerants, Others), By Application (Domestic, Industrial, Commercial, Air conditioning, Chillers, Variable refrigerant flow, Mobile air conditioning, Others) and
Polyethylene Terephthalate (PET) Market to Attract High Revenue from Rise in Dem …
The global polyethylene terephthalate (PET) market size is prognosticated to rise remarkably owing to the increasing demand for polyethylene terephthalate from the food and beverage sector. In a recent report by Fortune Business Insights™ titled, “Polyethylene Terephthalate (PET) Market Size, Share & Industry Analysis, By Grade (Textile, Bottle, Film), By End-Use Industry (Packaging, Textiles, Automotive, Electrical, and electronics) and Regional Forecast, 2019-2026,” the market is discussed in details. Browse Report Summary: https://www.fortunebusinessinsights.com/industry-reports/polyethylene-terephthalate-pet-market-101743 Some
Industrial Wax Market to Witness Progressive Growth Rate Owing to Rise in Demand …
The global industrial wax market size is likely to witness remarkable growth on account of the technological changes in the wax industry. Fortune Business Insights™ studies the industrial wax market in details in their report titled, “Industrial Wax Market Size, Share & Industry Analysis, By Type (Fossil based Wax, Synthetic based wax, Bio-based wax), By Application (Candles, Packaging, Coatings & Polishing, Tire & Rubber, Food, Cosmetics, Adhesives, Others) and Regional

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and